Duration of Dual Antiplatelet Therapy for Patients at High Bleeding Risk Undergoing PCI-Reference-Cited by-同舟云学术

Duration of Dual Antiplatelet Therapy for Patients at High Bleeding Risk Undergoing PCI

Published:2021-11 Issue:21 Volume:78 Page:2060-2072
ISSN:0735-1097
Container-title:Journal of the American College of Cardiology
language:en
Short-container-title:Journal of the American College of Cardiology

Author:

Valgimigli Marco,Cao Davide,Angiolillo Dominick J.,Bangalore Sripal,Bhatt Deepak L.,Ge Junbo,Hermiller James,Makkar Raj R.,Neumann Franz-Josef,Saito Shigeru,Picon Hector,Toelg Ralph,Maksoud Aziz,Chehab Bassem M.,Choi James W.,Campo Gianluca,De la Torre Hernandez Jose M.,Kunadian Vijay,Sardella Gennaro,Thiele Holger,Varenne Olivier,Vranckx Pascal,Windecker Stephan,Zhou Yujie,Krucoff Mitchell W.,Ruster Karine,Zheng Yan,Mehran Roxana

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference36 articles.

1. Evolution of antithrombotic therapy in patients undergoing percutaneous coronary intervention: a 40-year journey;Cao;Eur Heart J,2021

2. Associations of major bleeding and myocardial infarction with the incidence and timing of mortality in patients presenting with non-ST-elevation acute coronary syndromes: a risk model from the ACUITY trial;Mehran;Eur Heart J,2009

3. Trade-off of myocardial infarction vs bleeding types on mortality after acute coronary syndrome: lessons from the Thrombin Receptor Antagonist for Clinical Event Reduction in Acute Coronary Syndrome (TRACER) randomized trial;Valgimigli;Eur Heart J,2017

4. Validation of the academic research consortium high bleeding risk definition in contemporary PCI patients;Cao;J Am Coll Cardiol,2020

5. Validation of high bleeding risk criteria and definition as proposed by the academic research consortium for high bleeding risk;Corpataux;Eur Heart J,2020

Cited by 39 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. 1- Versus 3-Month DAPT in Older Patients at a High Bleeding Risk Undergoing PCI: Insights from the XIENCE Short DAPT Global Program;The American Journal of Cardiology;2024-03

2. Does Age Have a Differential Effect on 1 Month Versus 3 Months of Dual Antiplatelet Therapy After Percutaneous Coronary Intervention in Patients at High Bleeding Risk?;The American Journal of Cardiology;2024-02

3. Second-generation everolimus-eluting intracoronary stents: a comprehensive review of the clinical evidence;Future Cardiology;2024-01-31

4. After placement of a newer-generation drug-eluting coronary artery stent in a patient with a high bleeding risk, does one month of dual antiplatelet therapy effectively reduce the incidence of major bleeding while also maintaining stent effectiveness?;Evidence-Based Practice;2024-01-25

5. Aspirin-free antiplatelet strategies after percutaneous coronary interventions;European Heart Journal;2024-01-18